Results 161 to 170 of about 1,984,102 (295)

Safety of and serological response to a new canine distemper‐parvovirus combination vaccine in domestic ferrets

open access: yesVeterinary Record, EarlyView.
Abstract Background Pet ferrets are typically vaccinated against distemper using a canine multivalent vaccine despite the lack of relevant safety or efficacy data. Here, we investigate the safety of a novel live canine parvovirus type 2c (CPV‐2c) vaccine strain and the efficacy of the live Onderstepoort canine distemper virus (CDV) vaccine strain used ...
Jacqueline Pearce   +4 more
wiley   +1 more source

The Dark Pyramid: Unpacking the Multidimensional Nature of the Dark Side of Leadership

open access: yesBritish Journal of Management, EarlyView.
Abstract The dark side of leadership has been employed as an umbrella term to cover an array of concepts typically concerned with the dysfunctionality and/or toxicity of individual leaders. As the field of leadership studies moves towards ‘post‐heroic’ perspectives, we apply the same ontological positioning, adopting a ‘post‐villainous’ perspective in ...
Peter Stephenson   +2 more
wiley   +1 more source

Chronic Disease and Disability in the United States: Trends, Inequities, and Imperatives for Policy Reform

open access: yesThe Milbank Quarterly, EarlyView.
Policy Points Position Universal, High‐Quality Education as a Foundational Public Health Strategy. Long‐term health and life expectancy in the United States are shaped more by educational attainment than by any other single factor. Disparities in access to early childhood, K‐12, and higher education perpetuate cycles of chronic disease, economic ...
ALI H. MOKDAD   +2 more
wiley   +1 more source

US Life Expectancy and Increasing Mortality Rates: An Analysis of the Crisis

open access: yesThe Milbank Quarterly, EarlyView.
Policy Points US life expectancy is shorter than in other high‐income countries and the gap has widened dramatically over time, driven in particular by rising mortality rates that threaten the probability that youth can survive to middle age, or even adulthood.
STEVEN H. WOOLF
wiley   +1 more source

Methylene Blue Rescue Therapy for Vasoplegic Shock After Antihypertensive Drug Overdose. [PDF]

open access: yesAm J Case Rep
Aqel YHI   +5 more
europepmc   +1 more source

Child Health Challenges, Ecosystem Mismatches, and the Case for State‐Level Policy Innovation

open access: yesThe Milbank Quarterly, EarlyView.
Policy Points From 2011‐2023, US children's health deteriorated across >170 indicators. Chronic conditions rose from 25.8% to 31%, risk of anxiety tripled, and autism and learning disability more than doubled. Policies based on biomedical models have failed to address these trends.
NEAL HALFON, SHIRLEY RUSS
wiley   +1 more source

Prevalence of novel psychoactive substances in selected clinical urine specimens submitted for drug monitoring

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract Novel psychoactive substances (NPS) are compounds emerging as alternatives to more established drugs of abuse. They are constantly changing and being modified, which makes their detection difficult. The study objective was to determine the prevalence of NPS in selected clinical specimens. Deidentified urine specimen remnants were analyzed that
Jillian R. Neifeld   +2 more
wiley   +1 more source

Predicting drug overdose and death after "before medically advised" hospital discharge. [PDF]

open access: yesCMAJ
Naik H   +11 more
europepmc   +1 more source

Protodesnitazene: The identification and tissue distribution of a new nitazene

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract Multiple new analogues from the 2‐benzyl benzimidazole or “nitazene” class of drugs have emerged on the drug market in recent years. Nitazenes are highly potent μ‐opioid receptor agonists that present a substantial public health concern due to their elevated risk of severe toxicity in overdose and their significant potential for misuse.
Andrew Griffiths   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy